SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-180191
Filing Date
2018-05-31
Accepted
2018-05-31 15:29:02
Documents
1
Effectiveness Date
2018-05-31

Document Format Files

Seq Description Document Type Size
1 DEFA14A d558659ddefa14a.htm DEFA14A 14866
  Complete submission text file 0001193125-18-180191.txt   15885
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35347 | Film No.: 18871290
SIC: 2834 Pharmaceutical Preparations